NASDAQ:AXSM

Axsome Therapeutics Stock Insider Trading

etoro logo Buy AXSM
*Your capital is at risk
$237.33
-0.590 (-0.248%)
At Close: Jun 25, 2026

Axsome Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -79.45. In total, the insiders bought 1.52M and sold 641.23K AXSM shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-79.45
Buy 1.52M shares
Sell 641.23K shares
72% Buy Activity
Moderate Negative Correlation
Sell Signal High Confidence
Jun 09, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -79.45.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 11, 2026
Sell
Common Stock
S-Sale
Jeffs Roger
Director
Director 286
Value: $71.2K
Jun 10, 2026
Sell
Common Stock
S-Sale
Jeffs Roger
Director
Director 286
Value: $70.4K
Jun 10, 2026
Sell
Common Stock
S-Sale
Coleman Mark
Director
Director 643
Value: $160.1K
Jun 10, 2026
Sell
Common Stock
S-Sale
Mahony Susan
Director
Director 300
Value: $73.9K
Jun 09, 2026
Sell
Common Stock
S-Sale
Mahony Susan
Director
Director 300
Value: $71.2K
Jun 09, 2026
Sell
Common Stock
S-Sale
Pizzie Nick
Chief Financial Officer
C-Suite Officer 33 000
Value: $7.92M
Jun 09, 2026
Buy
Common Stock
M-Exempt
Tabuteau Herriot
Chief Executive Officer
CEO / President 49 670
Value: $245.9K
Jun 09, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Tabuteau Herriot
Chief Executive Officer
CEO / President 49 670
Value: $12.0M
Jun 09, 2026
Sell
Common Stock
S-Sale
Tabuteau Herriot
Chief Executive Officer
CEO / President 49 670
Value: $12.0M
Jun 09, 2026
Buy
Common Stock
M-Exempt
Pizzie Nick
Chief Financial Officer
C-Suite Officer 33 000
Value: $115.5K
Jun 09, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Pizzie Nick
Chief Financial Officer
C-Suite Officer 33 000
Value: $115.5K
Jun 08, 2026
Buy
Restricted Stock Units
M-Exempt
Coleman Mark
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Common Stock
M-Exempt
Jeffs Roger
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Restricted Stock Units
M-Exempt
Jeffs Roger
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Common Stock
M-Exempt
Saad Mark E
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Restricted Stock Units
M-Exempt
Saad Mark E
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Common Stock
M-Exempt
Mahony Susan
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Restricted Stock Units
M-Exempt
Mahony Susan
Director
Director 1 429
Value: $336.0K
Jun 08, 2026
Buy
Common Stock
M-Exempt
Coleman Mark
Director
Director 1 429
Value: $336.0K
Jun 05, 2026
Buy
Restricted Stock Units
A-Award
Jeffs Roger
Director
Director 1 721
Value: $399.8K
Jun 05, 2026
Buy
Restricted Stock Units
A-Award
Saad Mark E
Director
Director 1 721
Value: $399.8K
Jun 05, 2026
Buy
Restricted Stock Units
A-Award
Mahony Susan
Director
Director 1 721
Value: $399.8K
Jun 05, 2026
Buy
Restricted Stock Units
A-Award
Coleman Mark
Director
Director 1 721
Value: $399.8K
Jun 02, 2026
Sell
Common Stock
S-Sale
Coleman Mark
Director
Director 5 537
Value: $1.24M
Jun 01, 2026
Sell
Common Stock
S-Sale
Coleman Mark
Director
Director 6 000
Value: $1.38M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT AXSOME THERAPEUTICS
Axsome Therapeutics
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ...
GOLDEN STAR
Ticker Change Signal Date
JLL
$298.94
1.61% Jun 23
CBRE
$133.21
1.03% Jun 23
CAG
$13.43
2.72% Jun 23
TTEK
$28.04
1.43% Jun 23
NESR
$25.07
7.62% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE